Complete abortion rate · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Therapeutic ibuprofen 800 mg showed no clear difference in complete abortion rate compared with prophylactic ibuprofen 800 mg women having medical abortion before… (low certainty).
1 finding from 1 review
Induction to expulsion interval ‐ not reported · women having medical abortion before 14 weeks' gestation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Unscheduled contact with care · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Therapeutic ibuprofen 800 mg showed no clear difference in unscheduled contact with care compared with prophylactic ibuprofen 800 mg women having medical abortion before… (low certainty).
1 finding from 1 review
Patient satisfaction with analgesia ‐ not reported · women having medical abortion before 14 weeks' gestation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient satisfaction with abortion care overall ‐ not reported · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Therapeutic ibuprofen 800 mg showed no clear difference in patient satisfaction with abortion care overall compared with prophylactic ibuprofen 800 mg women having medical abortion before… (low certainty).
1 finding from 1 review
PTS symptoms ‐ intermediate term (1 to 6 months post intervention) PCL‐5a,d,e; PCL‐6f; Post‐traumatic Stress Diagnostic Scaleb (higher score = higher severity) · health problem or population
1 finding from 1 review
Symptoms of depression at 3 months post‐treatment · health problem or population
1 finding from 1 review
Psychological distress post‐treatment · health problem or population
1 finding from 1 review
Child behaviour · health problem or population
1 finding from 1 review
Externalising behaviours 3 months post‐treatment · health problem or population
2 findings from 1 review
Internalising behaviours 3 months post‐treatment · health problem or population
2 findings from 1 review
Quality of life ‐ mean change/endpoint all available scales (combined scales and time points) · patients with schizophrenia
1 finding from 1 review
Hospital readmission · patients with schizophrenia
It is very uncertain whether summary of findings table ‐ Antipsychotic dose reduction changes service use ‐ readmission to hospital (combined time points) compared with dose continuation (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with schizophrenia
Summary of findings table ‐ Antipsychotic dose reduction probably leads to higher adverse effect ‐ leaving the study early due to adverse effects ‐… compared with dose continuation (moderate certainty).
1 finding from 1 review
Functioning at · patients with schizophrenia
1 finding from 1 review
Global state ‐ number of participants with relapse/exacerbations of psychosis (combined time points) · patients with schizophrenia
Summary of findings table ‐ Antipsychotic dose reduction may leads to higher global state ‐ number of participants with relapse/exacerbations of… compared with dose continuation (low certainty).
1 finding from 1 review
Leaving the study early ‐ for any reason ‐ overall acceptability (combined time points) · patients with schizophrenia
Summary of findings table ‐ Antipsychotic dose reduction probably leads to higher leaving the study early ‐ for any reason ‐ overall acceptability… compared with dose continuation (moderate certainty).
1 finding from 1 review
Participants with at least some Side Effects · patients with schizophrenia
Summary of findings table ‐ Antipsychotic dose reduction showed no clear difference in adverse effects ‐ number of participants with at least 1 adverse… compared with dose continuation (moderate certainty).
1 finding from 1 review
HRQoL ‐ all domains (change from baseline) Scale: age‐appropriate versions of the CFQ‐R questionnaire · children and young adults with CF
1 finding from 1 review
Lung function: FEV1 mL (percentage change from baseline) · children and young adults with CF
It is very uncertain whether summary of findings ‐ Inhaled mannitol plus dornase alfa changes lung function: FEV1mL (percentage change from baseline) compared with dornase alfa (very low certainty).
1 finding from 1 review